Three patients who suffered from metastatic colorectal cancer were infused with NKG2D CAR NK cells locally, and the results showed that NKG2D CAR NK cells reduced tumor burden effectively without persistent or severe adverse events.109. The gene discussed is KLRK1; the disease is metastatic colorectal cancer.